Search

Your search keyword '"Viret F"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Viret F" Remove constraint Author: "Viret F"
268 results on '"Viret F"'

Search Results

1. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

2. Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study

3. Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

4. 260P Antitumor activity of trastuzumab deruxtecan (T-DXd) in patients with metastatic breast cancer (mBC) and brain metastases (BMs) from DAISY trial

5. LBA72 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial

6. Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

17. Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings†

24. Liver does not care about age

26. Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study

27. Highly emotionally loaded breaking bad news (BBN) scenarios: how to promote a Simulated Patients (SP) team’s motivation

28. Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study

29. Dose-escalation study using up to twice the standard dose of cetuximab in patients with metastatic colorectal cancer (mCRC) with no or slight skin reactions on cetuximab standard dose treatment (EVEREST study): Preliminary data.

31. FOLFIRI followed by radiochemotherapy and surgery in locally advanced gastric cancer: FFCD 0308 phase II trial.

32. BAYPAN study: A double-blind, phase III randomized trial of gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with advanced pancreatic cancer.

37. mFOLFOX-bevacizumab or XELOX-bevacizumab then bevacizumab (B) alone or with erlotinib (E) in first-line treatment of patients with metastatic colorectal cancer (mCRC): Interim safety analysis of DREAM study

38. Planned interim analysis of the intergroup FFCD-GERCOR-FNCLCC-AERO phase III study comparing two sequences of chemotherapy in locally advanced or metastatic gastric cancers

39. A multicenter, randomized phase II trial of gemcitabine and oxaliplatin (GEMOX) alone or in combination with biweekly cetuximab in the first-line treatment of advanced biliary cancer: Interim analysis of the BINGO trial

40. CO.133 Association Cetuximab-FOLFIRI en traitement de 1re intention du cancer colorectal métastatique : données de survie et impact du statut KRas de l’étude CRYSTAL

41. CO.74 Phase II randomisée comparant une bithérapie standard à trois schémas de chimiothérapie intensifiée en première ligne de traitement des patients atteints de métastases hépatiques non résécables d’un cancer colorectal : METHEP

42. CO.75 Phase II multicentrique évaluant l’association de cetuximab au schéma FOLFIRINOX chez des patients traités en première ligne métastatique pour un cancer colorectal métastatique (CCRM) : résultats préliminaires

43. CO.56 Etude de phase II randomisée évaluant une radio-chimiothérapie par docetaxel-cisplatine en cas de cancer du pancréas localement avancé. Résultats préliminaires de l’essai ACCORD9/0201 du groupe digestif de la FNCLCC

44. CO.58 Chimiothérapie par gemcitabine et oxaliplatine (GEMOX) seule ou combinée au cetuximab bimensuel en première ligne de traitement des cancers biliaires avancés : résultats préliminaires de l’essai de phase II randomisé multicentrique franco-allemand BINGO

45. CO.117 Analyse intermédiaire planifiée de l’essai de phase III intergroupe FFCD-GERCOR-FNCLCC-AERO comparant deux séquences de chimiothérapie dans les cancers gastriques métastatiques ou localement avancés

47. Preliminary results of a randomized phase II trial comparing standard bi-therapy versus three intensified chemotherapy regimens as treatment for patients with non resectable liver metastases from colorectal cancer (LMCRC). (METHEP)

Catalog

Books, media, physical & digital resources